Medical Health Screening Market Report 2026

Medical Health Screening Market Overview

• Medical Health Screening market size has reached to $19.74 billion in 2025 • Expected to grow to $26.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Burden Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Need For Early Detection And Preventive Care • Market Trend: Artificial Intelligence Innovations Revolutionizing Radiology And Cancer Screening • North America was the largest region in 2025.

What Is Covered Under Medical Health Screening Market?

Medical health screening refers to the systematic process of conducting various tests and examinations on apparently healthy individuals to identify potential health problems or risk factors before symptoms appear. This early detection approach enables healthcare providers to implement timely interventions, reduce the severity of diseases, and improve overall health outcomes through preventive measures. The main types of tests in medical health screening are routine tests, non-routine tests, cancer screening tests, specialty tests, and others. Routine tests are standard medical examinations performed regularly to monitor general health and detect potential issues early. It includes various sample types, such as blood, urine, saliva, and others, and caters to diverse end users, including hospitals or clinics, diagnostic laboratories, workplaces, research institutes, and others.

What Is The Medical Health Screening Market Growth Forecast?

The medical health screening market size is expected to see strong growth in the next few years. It will grow to $26.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising integration of digital health platforms, expansion of population-level screening initiatives, growing demand for home-based testing services, increasing focus on early cancer detection. Major trends in the forecast period include increasing adoption of preventive health screening programs, rising use of multi-parameter diagnostic panels, growing demand for early disease detection services, expansion of corporate and occupational health screening, enhanced focus on personalized screening protocols.

Global Medical Health Screening Market Segmentation

1) By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, Other Test Types 2) By Sample Type: Blood, Urine, Saliva, Other Sample Types 3) By End User: Hospitals Or Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Other End Users Subsegments: 1) By Routine Tests: Blood Pressure Monitoring, Blood Glucose Testing, Lipid Profile, Complete Blood Count (CBC), Urinalysis 2) By Non-Routine Tests: Genetic Testing, Hormonal Testing, Allergy Testing, Infectious Disease Testing 3) By Cancer Screening Tests: Mammography, Pap Smear Test, Colonoscopy, Prostate-Specific Antigen (PSA) Test, Low-Dose CT Scan For Lung Cancer 4) By Specialty Tests: Cardiovascular Screening, Neurological Screening, Pulmonary Function Tests, Bone Density Test 5) By Other Test Types: Wellness Tests, Executive Health Checkups, Prenatal Screening, Occupational Health Screening

What Is The Driver Of The Medical Health Screening Market?

The rising prevalence of chronic diseases is expected to propel the growth of the medical health screening market going forward. Chronic diseases refer to long-term health conditions, such as diabetes, heart disease, and asthma, that usually persist for a year or more and require continuous medical care or limit daily functioning. The prevalence of chronic diseases is rising due to sedentary lifestyles, as prolonged inactivity weakens the body's overall health and increases vulnerability to long-term medical conditions. Medical health screening is valuable for chronic diseases, as it allows for the early identification of risk factors and symptoms, enabling timely intervention and management that can prevent complications, improve quality of life, and reduce the overall burden of these long-term conditions. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based non-profit organization, as of today, 589 million adults aged 20–79 are living with diabetes worldwide, and this number is expected to rise to 853 million by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the medical health screening industry.

Key Players In The Global Medical Health Screening Market

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited

Global Medical Health Screening Market Trends and Insights

Major companies operating in the medical health screening market are focusing on introducing innovative solutions, such as artificial intelligence-powered radiology informatics and cancer screening, to enhance early detection, improve diagnostic accuracy, and streamline clinical workflows. AI-powered radiology informatics and cancer screening refer to the use of artificial intelligence technologies to analyze medical imaging data and identify potential signs of cancer or other abnormalities with greater speed and accuracy. For instance, in February 2025, DeepHealth, a US-based health informatics company, launched a new suite of AI-powered radiology informatics and cancer screening solutions powered by their cloud-native operating system, DeepHealth OS. This includes the Diagnostic Suite, a unified AI-driven diagnostic workspace, and advanced AI tools for lung, prostate, and brain health screening. These innovations aim to enhance clinical accuracy, streamline workflows, and improve operational efficiency across diverse healthcare settings.

What Are Latest Mergers And Acquisitions In The Medical Health Screening Market?

In January 2023, PAM Group, a UK-based provider of occupational health, rehabilitation, and absence management services, acquired MedProtect for an undisclosed amount. With this acquisition, PAM Group aims to strategically strengthen its position in the occupational health and wellbeing sector by incorporating MedProtect’s specialized mobile health screening services, enabling the combined entity to offer more cost-effective health solutions to a broader range of clients while supporting continued growth and innovation within the industry. MedProtect is a UK-based company that provides occupational health screening services, offering mobile health screening units for services such as hearing tests, biological monitoring, and lung function assessments.

Regional Outlook

North America was the largest region in the medical health screening market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Medical Health Screening Market?

The medical health screening market includes revenues earned by entities by providing services such as blood pressure measurement, mental health assessment, infectious disease screening, immunization status review, and lifestyle risk assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Health Screening Market Report 2026?

The medical health screening market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical health screening industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.